Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias

Published:2015-02-17 Issue:S1 Volume:10 Page:2-7
ISSN:1861-0706
Container-title:Clinical Research in Cardiology Supplements
language:en
Short-container-title:Clin Res Cardiol Suppl

Author:

Grützmacher P.,Kleinert C.,Dorbath C.,Öhm B.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Molecular Biology,General Medicine,Structural Biology

Link

http://link.springer.com/content/pdf/10.1007/s11789-015-0070-4.pdf

Reference26 articles.

1. Cuchel M, Bruckert E, Ginsberg H et al (2014) Homozygous familial hypercholesterolaemia: new insight and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J 35:2146–2157

2. Raal FJ, Pilcher GJ, Panz VR, van Deventer HE, Brice BC, Blom DJ, Marais D (2011) Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation 124:2202–2207

3. Raal FJ, Santos RD (2012) Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis 223:262–268

4. Reiner Z et al (2011) ESC/EAS guidelines for the management of dyslipidaemia of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769–1818

5. Robinson J et al (2014) Odyssey long-term and outcome study, Hotline session 707, ESC Congr. 2014, Barcelona, Spain

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changing from lipoprotein apheresis to evolocumab treatment lowers circulating levels of arachidonic acid and oxylipins;Atherosclerosis Plus;2024-03

2. Lipoproteinapherese;Herz;2022-04-22

3. Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis;Current Atherosclerosis Reports;2019-11-19

4. Activation of Lipid Mediator Formation Due to Lipoprotein Apheresis;Nutrients;2019-02-09

5. Efficacy of lipid reduction with DALI and MONET;Atherosclerosis Supplements;2017-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3